Top Markets
Coin of the day
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rank in Stocks #39233
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Share Price
$0.0045
Last synced: 2026-08-13
Market Cap
$591.52K
Change (1 day)
-10.00%
Change (1 year)
-86.76%
Country
US
Trade Burzynski Research Institute, Inc. (BZYR)

Category

Earnings for Burzynski Research Institute, Inc. (BZYR)
Earnings in 2026 TTM: 0
According to Burzynski Research Institute, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Burzynski Research Institute, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors